David Silvious
Analyst · BB&T. Please proceed with your question
All right. Thanks, Steve and good morning, everybody. Thanks for being with us this morning. Net sales for the quarter were $211.4 million compared to $220.2 million in the third quarter of 2014. It's a decrease of 4% or a $8.8 million decrease. International sales for were $55 million compared to $77.6 million for Q3 last year. It's a decrease of 29.1% or $22.6 million decrease. International sales represented 26% of Q3 sales this year and 35.2% of Q3 sales last year. The decrease in international sales compared to Q3 of last year occurred primarily in Canada and South American countries other than Brazil and in Australia and those decreases were offset by increases in Europe, in Southeast Asia and in Africa. Domestic sales for the quarter were $156.3 million compared to $142.6 million in Q3 of last year. It's a 9.6% increase or $13.7 million increase. Domestic sales represented 77% of Q3 sales this year and 64.8% of Q3 sales last year. Part sales for the quarter were $62 million compared to $61.5 million for Q3 last year. That's an increase of slightly less than 1% or a $500,000 increase. Part sales represented 29.3% of Q3 2015 sales compared to 28% of Q3 2014 sales. The foreign exchange translation of our foreign entities sales had a negative impact on those sales for the quarter of about $5.3 million. Now that is if the current year sales were translated at last year's rates, they would have been $5.3 million higher. On a year-to-date basis, net sales were $768.1 million compared to $736.1 million for the first nine months last year, a 4.3% increase or $32 million increase. International sales, on a year-to-date, were $206.1 million compared to $233.4 million for the first nine months last year. It's a decrease of 11.7% or a $27.3 million decrease. The year-to-date decrease in dollars for the first nine month period comparably occurred primarily in Russia, in South American countries other than Brazil, in China and Southeast Asia and in Mexico. Those decreases were offset by increases in Europe and the Middle East. International sales represented 26.8% of sales year-to-date compared to 31.7% of year-to-date sales last year. Domestic sales for the first nine months of 2015 were $562 million compared to $502.7 million last year, a $59.3 million increase or 11.8% increase. Domestic sales were 73.2% of 2015 sales compared to 68.3% of sales for the same period last year. Part sales were $202.5 million for the first nine months of this year compared to $191 million for the first nine months of last year, a 6% increase or $11.5 million increase. Part sales for the year-to-date period were 26.4% of total sales compared to 25.9% of total sales for the first nine months of 2014. Again, the foreign exchange translation of the sales of our foreign entities had a negative impact on sales for the first nine months of the year of $12.6 million, if they had been translated at last year's rates at 9/30, our sales would have been $12.6 million higher. Consolidated gross profit for the quarter was $45.1 million compared to $43.3 million, an increase of 4.2% or $1.8 million increase in gross profit. The gross profit percentage was 21.4% compared to 19.7% for Q3 of last year. The absorption variance for the quarter was about $5.4 million unabsorbed overhead compared to $5 million number in the same quarter last year. So we had a negative variance there of about $400,000. The foreign exchange transaction gain or loss in the income statement was $267,000 this year in Q3 compared to $712,000 in Q3 of last year. Year-to-date gross profit was $173.4 million compared to $162.2 million last year, $11.2 million increase or 6.9% increase. That resulted in a gross profit percentage for the first nine months of 22.6% compared to 22% for the same period last year. The absorption variance this year was $9.9 million through the first nine months unabsorbed overhead compared to $11.1 million unabsorbed overhead in 2014, a positive change of $1.2 million. The foreign exchange transaction gain or loss that's in the income statement in 2015 for the year-to-date period is $817,000 compared to $1.02 last year. Those are all losses, by the way, on the ForEx. SGA&E for the quarter was $41 million compared or 19.4% of sales compared to $38.9 million for the third quarter of last year at 17.7% of Q3 2014 sales. It's an increase of $2.1 million or in percentage of sales terms, 170 basis points increase. The drivers of the increase in SGA Q3 versus Q3 are primarily repairs and maintenance expense and some payroll and related benefits expense, including health insurance totaling about $2.8 million. For the year, SGA&E is $128.1 million or 16.7% of sales compared to $122.5 million last year or 16.6% of sales to $5.6 million increase or flat as a percentage of sales. The drivers there, recall that last year we had ConExpo which was about $4 million charge in the first quarter of 2013 and this year we have got, you would recall discussions last quarter computer and consulting type expenses related to ERP implementations, increased health insurance expense and various payroll and benefits related expenses, in addition to repairs and maintenance expense during the quarter, which totaled about $9.8 million. Operating income for the third quarter of 2015 was $4.1 million compared to $4.4 million last year in Q3. That is a $300,000 decrease or a 6.8% decrease. Year-to-date operating income was $45.3 million compared to $39.7 million last year, an increase of $5.6 million or 14.1% increase in operating income. Interest expense for the quarter was just over $500,000 compared to the third quarter of 2014 interest expense was $193,000, a $312,000 increase. And on a year-to-date basis, it was $1.222 million compared to $375,000 last year, an $87,000 increase. The primary driver of that interest expense is currently the debt that we have in Brazil to get that facility built and up and going. Other income, net of other expense, for the third quarter was $844,000 compared to $860,000 for Q3 of last year and year-to-date it was $3.2 million compared to $2.4 million for the year-to-date period last year. The primary source of that other income is license fee income, investment income kept at our capital insurance company. But do recall that earlier this year, the year-to-date amount in 2015 includes key main life insurance proceeds that were recognized in the first quarter of approximately $1.2 million. The effective tax rate for the quarter was 52.5% compared to 64% in Q3 of last year and the year-to-date effective tax rate was 38.8% compared to 37.9% for the year-to-date period last year. So the effective tax rate, again and the explanation is the same for both third quarters, was impacted by the net operating losses of certain of our foreign companies in foreign tax jurisdictions that could not be utilized to offset the taxable income here in the U.S. And there were various true-up adjustments related to prior year tax filings. So also recall that neither of the years during Q3 had the research and development tax credit in it, since that credit was not approved by Congress at September 30, in either of 2014 or 2015. Net income attributable to controlling interest is $2.3 million in the third quarter of 2015 compared to $1.9 million in the third quarter of 2014. It's a $400,000 increase or 21.1% increase. Diluted earnings for the quarter were $0.10 compared to $0.08 in Q3 of 2014, a $0.02 increase or 25% increase. On a year-to-date basis, net income attributable to controlling interest is $29.2 million compared to $26 million last year. It's an increase of $3.2 million or 12.3% increase in net income year-over-year. Diluted earnings per share for the year were $1.26 compared to $1.12 last year. That is a $0.14 increase or 12.5% increase. EBITDA for the quarter was $10.8 million compared to $11.2 million last year, a decrease of $0.5 million dollars or 4% decrease. On a year-to-date basis, EBITDA was $66.1 million compared to $59 million for the first nine months of last year, a $7.1 million increase or a 12.2% increase. The backlog at September 30 of 2015 was $245.6 million and that compares to $295 million at September 30, 2014, a $49.4 million decrease in backlog or 16.7% decrease. International backlog at September 30, 2015 was $58.1 million compared to $105.8 million at September 30, 2014, a decrease of $47.7 million or 45.1% decrease. The September 30 domestic backlog was $187.5 million compared to $189.2 million at 9/30/14, a decrease of $1.7 million or slightly less than a 1% decrease. Sequentially, the September 30, 2015 backlog compared to the June 30, 2015 backlog of $229.5 million is a $16.1 million increase or a 7% increase. The foreign currency translation impact on the backlog compared to 9/30 last year was a decrease of $7.4 million. So if they were, again if the backlog was translated at last year's rates for our foreign subsidiaries, it would have been $7.4 million greater. Our balance sheet continues to be very strong. We have receivables of $105.2 million compared to $108.8 million at 9/30 of last year, a decrease of $3.6 million. The days outstanding are 45.9 this year compared to 45.5 last year at 9/30. Inventories at $384.5 million compared to $370.4 million at 9/30/14, a $14.1 million increase. The turns are at two compared to 2.1 turns at 9/30/2014. At September 30, we owed $1.3 million on our $100 million dollars domestic credit facility and we had $14 million in cash and cash equivalents. Our letters of credit outstanding were $14.5 million and our borrowing availability is again $84.2 million at 9/30/15. Capital expenditures were $4.8 million for the quarter compared to 2015 and capital expenditures for the year-to-date period through the first nine months is $15.5 million. Comparing that to the budget for 2015 that we have discussed previously of $30.2 million. However, we don't believe that we are going to end up spending that much. We think we are going to end up somewhere in the $20 million range. Depreciation for the quarter is $5.1 million and for the year-to-date period it was $15.5 million. We had budgeted for 2015 $23.1 million in depreciation but with the sale of the Loudon facility and the reduction in fixed assets there, we believe we will end up somewhere just north of $20 million in depreciation for the year. That concludes my prepared remarks on the financial details. I will turn it back over to Steve.